Cooperative Agreement U01PS003327

This federal Project Grant award with ID R61HL172269, totaling $724,064.00, was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will fund the development and evaluation of a multi-level, integrated intervention called "HTN-Urban" to improve hypertension control among adults living in urban Vietnam. Key components of the intervention include a storytelling program, home blood pressure...

The Commonwealth of Virginia State Board of Health, Office of Epidemiology Division, has been awarded a $336,766 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The five-year award, effective January 1, 2025 through December 31, 2029, will support the Virginia Department of Health (VDH) TB Program's efforts to control, prevent, and eventually eliminate tuberculosis...

This $1,251,718 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will fund the Heart and Lung Outcomes Post-TB (HALO POST-TB) study. The study aims to elucidate the prevalence, trajectory, and mechanisms of cardiopulmonary abnormalities after tuberculosis (TB), and examine the role of HIV coinfection as an effect modifier. The research will enroll 480 individuals with a history of pulmonary TB and 120 healthy comparators in...

This three-year, $2.97 million Project Grant from the National Institutes of Health's Trans-NIH Research Support program will support the development of a novel lung research platform to probe pulmonary (patho)physiology in real-time at the cellular level. Trustees of Boston University will receive funding to create the LungEx platform, which includes long-term ex vivo maintenance of mouse and human lungs under near-physiological conditions. A key innovation is a "Crystal" ribcage that...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $743,698 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Trustees of Boston University to characterize the burden, severity, and phenotypic presentation of post-tuberculosis lung disease (PTLD) and its association with interleukin-6 (IL-6) signaling pathways in tuberculosis (TB) patients with and without HIV. The project will leverage an ongoing TB research consortium in India to...

The Hawaii Department of Health (DOH) was awarded a $815,916 five-year cooperative agreement (2025-2029) from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). This funding supports the DOH Tuberculosis Control Branch's comprehensive efforts to control and eliminate tuberculosis (TB) in the state of Hawaii. Key activities include screening for TB diagnosis, treating latent TB infection and...

This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $108,237 to Mbarara University of Science and Technology in Uganda to develop and assess the feasibility of a diagnostic tool for post-tuberculosis (TB) lung disease that can be deployed in primary healthcare settings with limited resources. The key objectives are to: (1) create and validate a clinical diagnostic algorithm for post-TB lung disease based on risk...

The South Dakota Department of Health received a $319,619 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116) to support tuberculosis (TB) prevention and control activities in South Dakota. The funding will support 2.26 FTEs, including a TB program manager, TB nurse consultant, and TB disease intervention specialist, as well as a portion of a TB laboratorian. Key...

This $300,000 cooperative agreement from the Centers for Disease Control and Prevention under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116) will support the Florida Department of Health in strengthening civil surgeons' capacity for latent tuberculosis infection (LTBI) surveillance and treatment of status adjusters. The Florida Civil Surgeon TB Consortium, comprising the Florida Department of Health TB Control Section, Miami-Dade Health...

This Project Grant award, valued at $246,000 and funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the role of lung repair and regeneration pathways in tuberculosis (TB) latency and reactivation. The key objectives are to determine the functional role of the bone morphogenetic protein (BMP) signaling pathway in TB control and reactivation, and to characterize the...